Companies
ChemoMetec
the NucleoCounter line (NC-200, NC-203, NC-3000) and the newer XcytoMatic platform use a closed reagent-cassette design that limits user contact with the sample, positioned for consistent counting in regulated manufacturing environments.
- Country
- Denmark
- Ticker
- CPH:CHEMM
CPH:CHEMM
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | 1997 | companydata.dk · investor.chemometec.com · globenewswire.com |
| Headquarters | Allerød, Denmark | investor.chemometec.com |
| Headcount | 170 employees (as of 2025-06-30) | companydata.dk · investor.chemometec.com · marketscreener.com |
| Revenue | DKK 495.6 million (FY 2024/25) | companydata.dk · investor.chemometec.com · globenewswire.com |
| Production site | Allerød, Denmark (head office and automated production facilities) | investor.chemometec.com |
| Regulatory approval | Instruments (NC-200, NC-203, XcytoMatic) are 21 CFR Part 11/GMP-ready | chemometec.com · investor.chemometec.com |
Independent sources: companydata.dk · globenewswire.com · marketscreener.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cell counters and viability systems | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.